` 2190 (Zylox-Tonbridge Medical Technology Co Ltd) vs Hang Seng (Hong Kong) Comparison - Alpha Spread

2190
vs
Hang Seng (Hong Kong)

Over the past 12 months, has significantly outperformed Hang Seng (Hong Kong), delivering a return of 62% compared to the Hang Seng (Hong Kong)'s 38% growth.

Stocks Performance
2190 vs Hang Seng (Hong Kong)

Loading

Performance Gap
2190 vs Hang Seng (Hong Kong)

Loading
2190
Hang Seng (Hong Kong)
Difference

Performance By Year
2190 vs Hang Seng (Hong Kong)

Loading
2190
Hang Seng (Hong Kong)
Add Stock

Competitors Performance
Zylox-Tonbridge Medical Technology Co Ltd vs Peers

Hang Seng (Hong Kong)
2190
ABT
ISRG
BSX
SYK
Add Stock

Zylox-Tonbridge Medical Technology Co Ltd
Glance View

Market Cap
5.3B HKD
Industry
Health Care

Zylox-Tonbridge Medical Technology Co., Ltd. operates as a medical devices company. The company is headquartered in Hangzhou, Zhejiang and currently employs 487 full-time employees. The company went IPO on 2021-07-05. The firm's main products include Thrombite Clot Retriever Device (Thrombite CRD) and Ultrafree Drug Coated PTA Balloon Catheter (Ultrafree DCB). The firm's products are sold to domestic and foreign markets.

Intrinsic Value
19.23 HKD
Undervaluation 16%
Intrinsic Value
Price
Back to Top